| Pharmaceutical active ingredients: |
| Fulvestrant |
| Available forms, composition and doses of Faslodex: |
| Injectable; Injection; Fulvestrant 50 mg / ml |
| Faslodex medical category: |
| Human:Antineoplastic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L02BA03 - Fulvestrant |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AstraZenecaFour StarVetter Pharma-FertigungZuellig Pharma |
| Related documents and information about Faslodex: |
| Faslodex prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ery-Max | Erythromycin; Erythromycin Ethylsuccinate | AstraZeneca; Schwarz Pharma |
| Ery-Maxin | Erythromycin; Erythromycin Ethylsuccinate | AstraZeneca |
| Eudur | Terbutaline Sulfate; Theophylline | AstraZeneca; Recipe, Austria |
| E-Vimin | Vitamin E (DL-Alpha Tocopherol Acetate) | AstraZeneca |
| Exanta | Melagatran; Ximelagatran | AstraZeneca |
| Feloday | Felodipine | AstraZeneca |
| Femanest | Estradiol | AstraZeneca; DuraScan Medical Products; Sandoz |
| Femanor | Estradiol; Norethindrone Acetate | AstraZeneca; Sandoz |
| Femasekvens | Estradiol; Norethindrone Acetate | AstraZeneca; DuraScan Medical Products; Sandoz |
| Fentanyl | Fentanyl Citrate | AstraZeneca |